Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1

Eitemau Tebyg

• Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
  gan: Tan, Benjamin, et al.
  Cyhoeddwyd: (2021)
• Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
  gan: Strauss, Julius, et al.
  Cyhoeddwyd: (2020)
• Bullous pemphigoid secondary to bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1
  gan: Wiggins, Claire J., et al.
  Cyhoeddwyd: (2021)
• Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma
  gan: Khasraw, Mustafa, et al.
  Cyhoeddwyd: (2021)
• Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
  gan: Paz-Ares, Luis, et al.
  Cyhoeddwyd: (2020)